Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Physical activity, height, and smoking affect prostate cancer risk.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Finasteride reduces bleeding during prostate surgery.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Certain natural compounds called terpenes may help prevent prostate cancer.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Ozone therapy might improve cancer treatment and reduce its side effects.

Hair shaft miR-221 levels can help detect malignant melanoma.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.